BeOne Medicines (BEIGF) EPS (Diluted) Growth (3y) (2019 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) EPS (Diluted) Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | 5.00% |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | 38.72% |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | 16.56% |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | -28.10% |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -36.04% |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | - |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | 46.09% |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 11.56% |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 36.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.83% |
| Mar 31, 2026 | 37.28% |
| Dec 31, 2025 | 28.78% |
| Sep 30, 2025 | 30.11% |
| Jun 30, 2025 | 29.11% |
| Mar 31, 2025 | 26.05% |
| Dec 31, 2024 | 39.03% |
| Sep 30, 2024 | 37.63% |
| Jun 30, 2024 | 39.64% |
| Mar 31, 2024 | -76.56% |
| Dec 31, 2023 | 16.27% |
| Sep 30, 2023 | 34.21% |
| Jun 30, 2023 | 5.58% |
| Mar 31, 2023 | 10.84% |
| Dec 31, 2022 | 12.56% |
| Sep 30, 2022 | 0.22% |
| Jun 30, 2022 | -53.87% |
| Mar 31, 2022 | -12.88% |
| Dec 31, 2021 | -10.75% |
| Sep 30, 2021 | -22.98% |